Valuation: Camurus AB

Market Cap 37.64B 3.75B 3.34B 3.12B 2.83B 5.34B 361B 5.38B 14.64B 184B 14.07B 13.77B 592B P/E 2026 *
38.6x
P/E 2027 * 26.8x
Enterprise Value 33.11B 3.3B 2.94B 2.74B 2.49B 4.7B 318B 4.73B 12.88B 162B 12.38B 12.11B 521B EV / Sales 2026 *
11.5x
EV / Sales 2027 * 8.61x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day+4.03%
1 week+2.68%
Current month+1.28%
1 month+7.75%
3 months+10.38%
6 months+30.79%
Current year+2.68%
1 week 608
Extreme 608
650
1 month 573.5
Extreme 573.5
650
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
710
3 years 304.2
Extreme 304.2
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
7/8/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/2/26 Sell

Chief Executive Officer

55,550 0.0928%
27/2/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
+4.03%+2.68%-7.80%+105.09% 3.61B
+0.02%-3.41%+36.11%+115.09% 1,019B
-1.21%-6.74%+34.08%+62.64% 617B
+1.12%+0.54%+13.62%+79.94% 464B
-3.30%-6.21%+56.45%+36.58% 356B
+0.93%-3.16%+21.65%+43.02% 333B
+0.12%-2.77%+10.70%+32.97% 267B
-0.89%-6.28%-7.00%+8.01% 244B
-0.01%-2.81%+35.28%+51.82% 218B
-0.08%-4.17%+28.34%+93.51% 179B
Average -0.30%-3.32%+22.14%+62.87% 370.08B
Weighted average by Cap. -0.55%-3.54%+28.47%+70.14%

Financials

2026 *2027 *
Net sales 2.88B 287M 256M 239M 217M 409M 27.65B 412M 1.12B 14.11B 1.08B 1.05B 45.37B 3.7B 369M 329M 307M 279M 525M 35.52B 529M 1.44B 18.13B 1.38B 1.35B 58.28B
Net income 979M 97.44M 86.92M 80.98M 73.7M 139M 9.38B 140M 381M 4.79B 366M 358M 15.39B 1.41B 140M 125M 117M 106M 200M 13.5B 201M 548M 6.89B 526M 515M 22.16B
Net Debt -4.53B -451M -402M -375M -341M -642M -43.41B -647M -1.76B -22.16B -1.69B -1.66B -71.21B -5.76B -574M -512M -477M -434M -817M -55.27B -823M -2.24B -28.21B -2.15B -2.11B -90.67B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
06/10/26 SEK 632.50 +4.03% 151,374
02/10/26 SEK 608.00 -2.49% 71,387
01/10/26 SEK 623.50 -0.16% 76,356
30/09/26 SEK 624.50 -0.08% 103,322
29/09/26 SEK 625.00 -0.87% 75,287
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
608.00SEK
Average target price
797.50SEK
Spread / Average Target
+31.17%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock